University of Torino

The consortium aims to profile up to 800 multiple myeloma patient samples using the Affymetrix platform with a goal of developing a list of predictive biomarkers.

The new subsidiary will focus on expanding the company's liquid biopsy technology capabilities and growing European adoption of its platform.

The partners will compare Adaptive Bio's clonoSeq MRD test with flow cytometry for accuracy and reliability in monitoring MRD in multiple myeloma patients. 

As research reveals tumor features that can affect circulating tumor DNA levels, investigators are considering several sequencing and PCR-based clinical applications for the bloodstream-borne nucleic acids — from early detection and diagnosis to minimal residual disease monitorin

NEW YORK (GenomeWeb News) – A study in Science Translational Medicine has started cataloguing the characteristics, constraints, and potential clinical applications of circulating tumor DNA.

Horizon Discovery also plans to participate in a consortium of "top academic institutions and big pharmas" in the cancer field, a research partnership expected to expand its panel of isogenic cell lines for drug discovery.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.